Historical record - last NADAC effective date: 2/22/2017

Product Information

AMLODIPINE BESYLATE 5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0168 per EA under NDC 65862010299. Its NADAC has been published 170 times since Nov 28, 2013.

FDA first approved this application on Jul 17, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Amlodipine Besylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AMLODIPINE BESYLATE 5 MG TAB

Amlodipine Besylate
$0.0168per EA
High Outlier

Strength

5 mg/1

NDC

65862010299

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/22/2017

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078021

FDA Approved

7/17/2007

TE Code

AB

On Market Since

7/17/2007

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE BESYLATE 5 MG TAB has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0168 per EA
All-time high$0.0221 (Feb 12, 2014)
All-time low$0.0168 (Feb 22, 2017)
Median price$0.0194
Average price$0.0193
Largest weekly change-15.9% (May 18, 2016)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-23.1%

Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE BESYLATE 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.0168 per EA (NDC 65862010299), effective Feb 22, 2017.

How has the price of AMLODIPINE BESYLATE 5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 5 MG TAB has declined 23.1%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 5 MG TAB?

Since Nov 28, 2013, the NADAC for AMLODIPINE BESYLATE 5 MG TAB has ranged from a low of $0.0168 (Feb 22, 2017) to a high of $0.0221 (Feb 12, 2014), with a median of $0.0194 per EA.

Are there cheaper alternatives to AMLODIPINE BESYLATE 5 MG TAB?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 5 MG TAB, is $0.0101 per EA — about 40% below AMLODIPINE BESYLATE 5 MG TAB.

Who manufactures AMLODIPINE BESYLATE 5 MG TAB?

AMLODIPINE BESYLATE 5 MG TAB (NDC 65862010299) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.